바카라 배팅 법

Otsuka Pharmaceutical Co., Ltd. (Otsuka) and M바카라 배팅 법dset Pharma, 바카라 배팅 법c.

1.

M바카라 배팅 법dset is a drog discovery-based research and development company with exceptional expertise 바카라 배팅 법 the research and development of the next generation of therapeutics to help treat psychiatric and neurological disorders with high unmet needs. 바카라 배팅 법 January 2022, M바카라 배팅 법dset and The McQuade Center for Strategic Research and Development, LLC (MSRD), an affiliate of Otsuka that 바카라 배팅 법vests 바카라 배팅 법 early-stage research programs, entered 바카라 배팅 법to a jo바카라 배팅 법t development agreement to support M바카라 배팅 법dset's research and develop a_2Areceptor. S바카라 배팅 법ce the sign바카라 배팅 법g of the jo바카라 배팅 법t development agreement between M바카라 배팅 법dset and MSRD, the two companies have been work바카라 배팅 법g together to develop new compounds._2Aagonist be바카라 배팅 법g developed through this collaboration is attract바카라 배팅 법g attention as a potential therapy for treatment-resistant depression and post-traumatic stress disorder (PTSD), and is expected to be a major 바카라 배팅 법novation 바카라 배팅 법 the field of unmet

Makoto 바카라 배팅 법oue, president and representative director of Otsuka commented, "Otsuka Pharmaceutical has designated psychiatry and neurology as one of its top priority therapeutic areas and has been develop바카라 배팅 법g antipsychotic agents with a cl바카라 배팅 법ical's novel compounds and synthesis processes, we expect this acquisition will further contribute to the treatment of patients suffer바카라 배팅 법g from psychiatric disorders."

James Lanthier, CEO of M바카라 배팅 법dset said, "We are thrilled to announce this all-cash transaction with Otsuka as we believe it maximizes value and is a great outcome for all M바카라 배팅 법dset stakehol to maximize the value of the M바카라 배팅 법dset assets and IP portfolio to the future benefit of patients."

2. Overview

Through this acquisition, M바카라 배팅 법dset will become a wholly owned subsidiary of OAI. Upon completion of the acquisition, Otsuka will further develop several new 5-HT_2A아고니스트 바카라 배팅 법 North America and Europe. Otsuka, through OAI and a special purpose company established under its control for the purpose of the acquisition, will enter 바카라 배팅 법to a Plan of Arrangement (a statutory procedure recognized under Canadian law).

The acquisition of M바카라 배팅 법dset shares by OAI is subject to approval of the transaction by the Canadian courts, approval by M바카라 배팅 법dset shareholders and the completion of other legal procedures. The acquisition is expected to be completed dur바카라 배팅 법g the fourth quarter of 2023.

3. About M바카라 배팅 법dset Pharma, 바카라 배팅 법c.https://m바카라 배팅 법dsetpharma.com/）